Palantir Technologies posts 96% growth and strong margins, but 52x forward sales raises risk. Click for this PLTR earnings ...
Tech Times on MSN
FDA Clears Voceryq as First Plasmid DNA Immunotherapy for Recurrent Respiratory Papillomatosis
Voceryq FDA approval marks the first US regulatory clearance for plasmid DNA-based immunotherapy. Inovio Pharmaceuticals ...
On this episode of CoinDesk’s Public Keys from the New York Stock Exchange, Jennifer Sanasie is joined by co-host Tim Grant, Co-Founder and CEO of TensorX, as crypto reckons with the largest hack in ...
Hourly smart meter readings can now reveal far more than a building's total electricity consumption. Researchers have ...
Engineers are replacing static prompts with dynamic context control planes that separate memory, knowledge, and real-time ...
Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect ...
<?xml encoding="utf-8" ?> SanDisk SNDK reported first-quarter financial results on Thursday. The transcript from the ...
Explore two AI experiments investigating contextual token representations, Transformer hidden states, and the accuracy of ...
Buy Unity (U) and sell AppLovin (APP) as U’s Strategic Grow revenue accelerates while APP faces downgrades and decelerating growth.
Introduction Recurrent stroke remains a major threat after an index stroke, but individual risk is difficult to estimate because recurrence reflects interacting clinical, imaging, treatment, ...
A new open-access study reports that fusing attribute features with graph structure and training classifiers collaboratively ...
Takumi and Haru's [Journey to Brush Off the Mud and Walk on Their Own Two Feet]Chapter 2: [The Little Newspaper Delivery Boy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results